openPR Logo
Press release

Anterior Uveitis Market To Register Substantial Expansion By 2020

01-19-2018 12:18 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anterior Uveitis Market To Register Substantial Expansion

Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition of the eye and also to reduce glare of the light that enters by absorbing the light and reducing internal reflection within the eye. In addition the uvea also helps in generating the aqueous humour and in controlling the focus of the eye lens. The uvea also consists of lymphocytes and is therefore prone to respond to inflammation by developing lymphocytic infiltrates. Uveitis is therefore a condition that requires urgent response from an ophthalmologist and immediate treatment.

Anterior Uveitis mainly includes iritis, which is known as the inflammation of the anterior chamber and the iris, and iridocyclitis, which is inflammation of the iris anterior chamber and the vitreous cavity. Anterior uveitis presents itself as redness of the eyes, irregular pupils, photophobia, blurred vision, eye pain/pressure, floaters visible to the patient, headaches, iridocyclitis induced cataract/glaucoma or synechia (attachment of iris to cornea or lens). The causative factors for uveitis has not yet been confirmed, however in half of the anterior uveitis cases a correlation was observed with the presence of HLA-B27 gene, which is a type of human leukocyte antigen (HLA) that increases the probability of an individual to contract uveitis by 15%. Anterior uveitis or acute anterior uveitis is the most common form of uveitis. Uveitis is primarily found to be systemic immune based; however possible causative factors in many cases also include infections from: Brucellosis, Leptospirosis, Lyme disease, Tuberculosis, Syphilis, Toxoplasmic chorioretinitis, Toxocariasis, or ocular histoplasmosis syndrome. Besides these drug interactions like rifabutin can also cause uveitis. Basically Uveitis occurs from the failed or hyperactive ocular immune response, this results in tissue destruction and inflammation, followed by buildup of mucus in extreme cases, hence the increased pressure.

The treatment for uveitis is mainly symptom specific, with steroids and non-steroidal anti inflammatory drugs ins the form of eye drops, or oral medications. Corneal ulcers if present may pose as complications hence anti-inflammatory medication is prescribed only after ruling out this disorder. Cyclopegics or ciliary muscle relaxants are administered for diagnosis or certain surgical treatment if necessary. Anti TNF agents and other anti metabolite medications may prove helpful in cases of severe uveitis, e.g. infliximab.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2956

Certain drugs like metformin, which is generally used as anti-diabetic drug has also been found to reduce inflammation in uveitis. Recent drugs like gevokizumab have undergone trials to for uveitis without infectious origin. The treatments given vary with the causative factor of uveitis, but overall the condition usually recedes after proper care and procedures are followed. In severe adverse cases, vision loss or cataract/glaucoma may occur, such cases however occur in very rare occasions. The incidence rate is as high as one in 4500 individuals globally according to a medical journal on ocular immunology. The incidence rates in developed countries of the west are higher than the developing countries in Asia and Africa. The market for anterior uveitis is therefore restricted to North American and European region, followed by Asia, South America and Rest of the World.

Some of the companies involved in the production of uveitis related drugs include: Novartis AG, Amdipharm Mercury Company Limited, Santen pharmaceuticals, etc.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=2956<ype=S

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anterior Uveitis Market To Register Substantial Expansion By 2020 here

News-ID: 909156 • Views:

More Releases from Transparency Market Research

Photochromic Lenses Market Size & Share to Surpass USD 10.9 Bn by 2031, Exhibiting a CAGR of 5.5% | States Transparency Market Research, Inc
Photochromic Lenses Market Size & Share to Surpass USD 10.9 Bn by 2031, Exhibiti …
Photochromic lenses, known for their ability to adjust to varying light conditions, are gaining significant traction in the eyewear industry. These adaptive lenses darken on exposure to sunlight and clear up indoors, providing convenience and protection. Available in various materials and incorporating advanced technologies, photochromic lenses cater to diverse consumer needs, enhancing their appeal and functionality. In 2022, the global photochromic lenses market was valued at an impressive US$ 6.8 billion.
Hysteroscopes Market Projected to Reach USD 446.6 Mn by 2031, Growing at a CAGR of 5.8%- Transparency Market Research, Inc.
Hysteroscopes Market Projected to Reach USD 446.6 Mn by 2031, Growing at a CAGR …
The hysteroscopes market is poised for significant growth over the next decade, driven by advancements in medical technology and increasing demand for minimally invasive procedures. These specialized medical devices are crucial in the examination and treatment of the uterine cavity, providing both diagnostic and therapeutic benefits. As healthcare technology evolves, hysteroscopes are becoming more sophisticated, offering enhanced precision and patient comfort. This article delves into the projected growth, key drivers,
Respiratory Devices Market Size/Share Worth USD 37.7 Bn by 2031, at a CAGR of 6.1% | Exclusive Report by Transparency Market Research, Inc.
Respiratory Devices Market Size/Share Worth USD 37.7 Bn by 2031, at a CAGR of 6. …
The global respiratory devices market is on the brink of substantial growth, driven by a convergence of technological advancements, an increasing prevalence of respiratory diseases, and demographic shifts such as an aging population. From therapeutic devices like ventilators and inhalers to diagnostic and monitoring tools such as spirometers and pulse oximeters, the respiratory devices market is poised to see a significant upsurge in demand over the coming decade. This detailed
Sharps Containers Market Worth USD 1.0 Bn, at a 4.7% CAGR By 2031 - Transparency Market Research, Inc.
Sharps Containers Market Worth USD 1.0 Bn, at a 4.7% CAGR By 2031 - Transparency …
In the realm of healthcare, the safe disposal of sharps-needles, syringes, and other sharp medical instruments-is not just a regulatory requirement but a crucial element of infection control and workplace safety. The global sharps containers market, valued at US$ 701.1 million in 2022, is set to expand significantly, projected to reach US$ 1.0 billion by 2031 with a steady compound annual growth rate (CAGR) of 4.7%. This growth trajectory underscores

All 5 Releases


More Releases for Uveitis

Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &
Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and